Hwei-Chung Wang Selected Research

Hwei-Chung Wang Research Topics

Disease

27	Breast Neoplasms (Breast Cancer) 05/2021 - 01/2008
14	Neoplasms (Cancer) 05/2018 - 04/2008
5	Neoplasm Metastasis (Metastasis) 09/2014 - 01/2012
4	Triple Negative Breast Neoplasms 05/2021 - 01/2014
3	Carcinogenesis 05/2021 - 01/2014
2	Hand-Foot Syndrome 06/2018 - 12/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2011 - 12/2009
2	Genomic Instability 12/2009 - 09/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Vomiting 03/2016
1	Nausea 03/2016
1	Alopecia (Baldness) 03/2016
1	Mucositis 03/2016
1	Neutropenia 12/2014
1	Pain (Aches) 09/2014
1	Multiple Myeloma 10/2013
1	Prostatic Neoplasms (Prostate Cancer) 10/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2012
1	Lung Neoplasms (Lung Cancer) 10/2012
1	Disease Progression 05/2012
1	Neuroendocrine Carcinoma 01/2012
1	Stomach Neoplasms (Stomach Cancer) 05/2011
1	Colorectal Neoplasms (Colorectal Cancer) 08/2010

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2008
4	DNA (Deoxyribonucleic Acid)IBA 05/2011 - 09/2009
3	AnthracyclinesIBA 06/2018 - 12/2014
3	1-dodecylpyridoxal (PLD)IBA 06/2018 - 12/2014
3	liposomal doxorubicin (Doxil)FDA Link 06/2018 - 12/2014
3	Matrix Metalloproteinases (MMPs)IBA 05/2018 - 01/2017
3	Zoledronic Acid (Zometa)FDA Link 09/2014 - 10/2013
3	Caveolin 1IBA 10/2011 - 08/2010
2	Estrogen ReceptorsIBA 09/2016 - 01/2012
2	Cisplatin (Platino)FDA LinkGeneric 05/2012 - 06/2011
2	Docetaxel (Taxotere)FDA Link 05/2012 - 06/2011
2	Hormones (Hormone)IBA 01/2012 - 06/2011
2	Tumor Biomarkers (Tumor Markers)IBA 01/2012 - 09/2011
2	exodeoxyribonuclease IIBA 12/2009 - 09/2009
2	Codon (Codons)IBA 12/2009 - 01/2008
1	Interleukin-10 (Interleukin 10)IBA 05/2021
1	Interleukin-13IBA 12/2020
1	Epirubicin (Ellence)FDA LinkGeneric 06/2018
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 05/2018
1	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 01/2018
1	ORALIT (ORS)IBA 01/2017
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2017
1	EnzymesIBA 01/2017
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2017
1	Estradiol (Delestrogen)FDA LinkGeneric 09/2016
1	Tamoxifen FDA LinkGeneric 09/2016
1	Goserelin (Zoladex)FDA Link 09/2016
1	Proteins (Proteins, Gene)FDA Link 03/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016
1	Metalloproteases (Metalloproteinases)IBA 03/2016
1	Tissue Inhibitor of Metalloproteinase-1IBA 03/2016
1	Antineoplastic Agents (Antineoplastics)IBA 12/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2014
1	Estrogens (Estrogen)FDA Link 08/2014
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 08/2014
1	Cyclin D1IBA 01/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2012
1	Trastuzumab (Herceptin)FDA Link 05/2012
1	Progesterone FDA LinkGeneric 01/2012
1	Letrozole (Femara)FDA LinkGeneric 01/2012
1	Carcinoembryonic AntigenIBA 01/2012
1	ChromograninsIBA 01/2012
1	4-chloronitrobenzene (PNCB)IBA 01/2012
1	SynaptophysinIBA 01/2012
1	NucleotidesIBA 10/2011
1	3-methylcytidineIBA 09/2011
1	NucleosidesIBA 09/2011
1	Inosine FDA Link 09/2011
1	CytidineIBA 09/2011
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 09/2011
1	alpha-Crystallin B ChainIBA 09/2011
1	Capecitabine (Xeloda)FDA Link 06/2011
1	Fluorouracil (Carac)FDA LinkGeneric 04/2008
1	Thymidylate SynthaseIBA 04/2008

Therapy/Procedure

6	Therapeutics 05/2018 - 06/2011
4	Drug Therapy (Chemotherapy) 06/2018 - 04/2008
3	Adjuvant Chemotherapy 06/2018 - 12/2014
2	Neoadjuvant Therapy 05/2012 - 06/2011
1	Mastectomy (Mammectomy) 11/2013